By vgreene, 7 May, 2020 STEMI: Use PPE as directed by local authorities; PCCI for most pts; pharmaco-invasive tx per region practice; if mod/high prob of COVID-19, consider alt investigations (TTE and/or CCT) prior to cath lab activation or pharmaco-invasive tx
By vgreene, 7 May, 2020 Elective cath cases: out-pt w/ sx and non-invasive testing showing high risk for event in short-term
By vgreene, 7 May, 2020 NSTEMI/UA: Invasive strategy if high risk NSTEMI; selective invasive strategy if med risk; medical tx if low risk or UA1
By vgreene, 7 May, 2020 STEMI: Use PPE as directed by local authorities; PCI for most pts; pharmaco-invasive tx per region practice; if mod/high prob of COVID-19, consider alt investigations (TTE and/or CCT) prior to cath lab activation or pharmaco-invasive tx
By vgreene, 7 May, 2020 Refractory COVID-19. Phase 2 open-label study in severe/critically ill pts; NAC IV 6 g/day4